Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial. (Q30369228)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial. |
scientific article |
Statements
1 reference
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial. (English)
1 reference
Albert D M E Osterhaus
1 reference
Ron A M Fouchier
1 reference
Guus F Rimmelzwaan
1 reference
Asisa Volz
1 reference
Eric C M van Gorp
1 reference
Joost H C M Kreijtz
1 reference
Fleur M Moesker
1 reference
Lennert van den Dries
1 reference
Simone Goeijenbier
1 reference
Heidi L M De Gruyter
1 reference
Michael H Lehmann
1 reference
Gerrie de Mutsert
1 reference
David A M C van de Vijver
1 reference
30 October 2014
1 reference
1 reference
Identifiers
1 reference